Administrative Core
Administrative Core
批准号:
10395996
负责人:
Frances E. Lund
金额:
$44.45万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2024-03-31
关键词:
AccountingAdaptive Immune SystemAntibodiesAntigensAsthmaAutoimmunityB-LymphocytesBloodBudgetsCD4 Positive T LymphocytesCardiovascular DiseasesCell FractionCell LineageCell TransplantationCellsCellular biologyCollaborationsCollectionDataDiabetes MellitusEffector CellElephantsEnsureEventExpenditureFeedbackFinancial SupportFosteringFutureGoalsGraft RejectionGrantGuidelinesHealthHealth Care CostsHeterogeneityHost DefenseHumanHuman ResourcesImmuneImmune systemImmunityImmunologyIndividualInfectionInstitutionInvestigationInvestmentsMediatingMedicineMemoryMemory B-LymphocyteMolecularMonitorMorbidity - disease rateMusOrganParticipantPathologicPlasma CellsPlayPoliciesProductionProgress ReportsPropertyRegulationReportingResearchResearch PersonnelResearch Project GrantsResearch SupportRoleScheduleScientistServicesStudy modelsTailTimeTissuesTransplantationTravelUnited States National Institutes of HealthUniversitiesVisitWorkarmchemokinechronic inflammatory diseasecytokinehuman tissueimmune functioninsightinterestlecturermeetingsmembermortalitymouse modelpathogenic bacteriapathogenic virusprogramsresponsesuccesssymposiumtissue injurytissue repairtumor-immune system interactions
中文摘要
核心A:行政核心
项目摘要
免疫系统在保护我们免受感染和解决或修复组织损伤方面起着至关重要的作用。
在感染或其他造成损害的环境侮辱之后。免疫系统也是一个主要的
慢性炎症性疾病的推动者,这些疾病推高了医疗保健成本和发病率和死亡率
美国,包括心血管疾病、糖尿病、自身免疫、哮喘、移植排斥反应和许多其他疾病。
在过去的三十年里,我们学到了很多关于免疫细胞如何发育和成熟,如何免疫
细胞被激活并分化为“效应”细胞,免疫细胞记忆是如何启动和维持的
以及免疫细胞如何在功能上对免疫介导的保护和损害做出贡献。在这辆U19
计划中,我们对B系细胞特别感兴趣,它通过呈现
抗原和激活CD4T细胞,通过产生
细胞因子和趋化因子,最重要的是,通过分化为短期和长期抗体
产生浆细胞(ASCs)和长寿记忆B细胞。这些细胞负责体液臂
是适应性免疫系统的关键,是宿主抵御大多数病毒和细菌病原体的关键。
然而,ASCs产生的抗体也是与以下疾病相关的组织损伤的主要原因
自身免疫、哮喘和移植。我们对血管紧张素转换酶的保护和病理功能的许多见解
B淋巴细胞和ASCs来自转基因小鼠模型研究,尽管这些
研究提供了非常丰富的信息,很明显,老鼠和人类不是一模一样的,有必要
为了更好地了解人类B细胞如何对免疫(Dys)功能做出贡献。我们对人类B细胞的研究是
仍然是非常初级的--很大程度上是因为研究仅限于容易接触到的循环血液
车厢。这就相当于研究大象的尾巴而不看整头大象--我们
当我们只检查B细胞中的一小部分时,我们忽略了B细胞的大部分复杂性和异质性
都存在于人体内。在这款U19中,我们计划超越大象尾巴,因为我们的目标是
全面检测人类B细胞的分子、细胞和功能特性
尤其是在不易接触到的人体组织和器官中。核心A的主要目标是提供
监督和支持整个计划以及个别项目和核心。我们将实现这一目标
通过:(1)向所有项目和核心提供科学、行政、监管和财务监督;和(2)
组织科学互动,包括该计划的每月进行中的研究会议
科学家与科学顾问委员会的年度务虚会,与其他合作社的年度会议
东南部人类免疫学团体中心和人类免疫学主题会议
免疫学研讨会。通过这些活动,核心A将确保该计划的全面成功。
英文摘要
Core A: Administrative Core
Project Summary
The immune system plays a critical role in protecting us from infection and resolving or repairing tissue injury
following infection or other environmental insults that cause damage. The immune system is also a major
contributor to chronic inflammatory diseases that drive health care costs and morbidity and mortality in the
U.S., including cardiovascular disease, diabetes, autoimmunity, asthma, transplant rejection and many others.
Over the last three decades we have learned much about how immune cells develop and mature, how immune
cells are activated and differentiate into “effector” cells, how immune cell memory is initiated and maintained
and how immune cells contribute in a functional way to immune-mediated protection and damage. In this U19
Program, we are particularly interested in B lineage cells that contribute to immune function by presenting
antigen and activating CD4 T cells, by altering the immune microenvironment through the production of
cytokines and chemokines and, most importantly, by differentiating into short- and long-lived antibody
producing plasma cells (ASCs) and long-lived memory B cells. These cells are responsible for the humoral arm
of the adaptive immune system and are key to host defense against most viral and bacterial pathogens.
However, antibodies produced by ASCs are also responsible for much of the tissue damage associated with
autoimmunity, asthma and transplantation. Many of our insights into the protective and pathologic functions of
B lymphocytes and ASCs have come from genetically modified mouse model studies and, although these
studies have been very informative, it is clear that mice and humans are not identical and that there is a need
to better understand how human B cells contribute to immune (dys)function. Our studies of human B cells are
still quite rudimentary – largely because the studies have been limited to the easily accessible circulating blood
compartment. This is the equivalent of studying the tail of the elephant without seeing the whole elephant – we
miss most of the complexity and heterogeneity of B cells when we only examine a tiny fraction of the cells that
are present in the body. In this U19, we plan to move beyond the elephant tail as our goal is to
comprehensively examine the molecular, cellular and functional properties of human B cells that reside
specifically in the less accessible human tissues and organs. The major objective of Core A is to provide
oversight and support for the overall Program and the individual projects and cores. We will meet this objective
by: (i) providing all projects and cores with scientific, administrative, regulatory and financial oversight; and (ii)
organizing scientific interactions, including the monthly research in progress meetings for the Program
scientists, the annual retreat with the scientific advisory board, the annual meeting with other Cooperative
Centers on Human Immunology groups and the Human Immunology themed session at the Southeastern
Immunology Symposium. Through these activities, Core A will ensure the overall success of the Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
-
批准号:10642784
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
-
批准号:10431929
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
Tissue and organ specific human B cell immunity
-
批准号:10265689
-
项目类别:
-
资助金额:$44.49万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
-
批准号:10032785
-
项目类别:
-
资助金额:$72.54万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination
-
批准号:10227903
-
项目类别:
-
资助金额:$73.54万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination
-
批准号:10455632
-
项目类别:
-
资助金额:$73.54万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
-
批准号:10214491
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues
-
批准号:10592418
-
项目类别:
-
资助金额:$94.58万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Tissue and organ specific human B cell immunity
-
批准号:10592408
-
项目类别:
-
资助金额:$355.3万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Administrative Core
-
批准号:10592409
-
项目类别:
-
资助金额:$9.93万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Infrastructure and Opportunity Fund Management Core
-
批准号:10592414
-
项目类别:
-
资助金额:$145.47万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues
-
批准号:10396002
-
项目类别:
-
资助金额:$44.45万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Tissue and organ specific human B cell immunity
-
批准号:10395994
-
项目类别:
-
资助金额:$355.62万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Infrastructure and Opportunity Fund Management Core
-
批准号:10396000
-
项目类别:
-
资助金额:$44.45万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
-
批准号:8806524
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of B cell differentiation by IFNg induced transcription factors
-
批准号:10307593
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of B cell differentiation by IFNg induced transcription factors
-
批准号:10521294
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
-
批准号:8992350
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of B cell differentiation by IFNg induced transcription factors
-
批准号:9887750
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
-
批准号:9204378
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
海外基金